Ripretinib

Ripretinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T8482-1mg 1 mg

7 - 10 business days*

67.00€
TGM-T8482-2mg 2 mg

7 - 10 business days*

96.00€
TGM-T8482-5mg 5 mg

7 - 10 business days*

164.00€
TGM-T8482-1mL 1 ml

7 - 10 business days*

208.00€
TGM-T8482-10mg 10 mg

7 - 10 business days*

282.00€
TGM-T8482-25mg 25 mg

7 - 10 business days*

482.00€
TGM-T8482-50mg 50 mg

7 - 10 business days*

702.00€
TGM-T8482-100mg 100 mg

7 - 10 business days*

967.00€
TGM-T8482-500mg 500 mg

7 - 10 business days*

1,943.00€
 
Description: Ripretinib (DCC-2618) is an orally bioavailable inhibitor of (KIT) and (PDGFRA).... more
Product information "Ripretinib"
Description: Ripretinib (DCC-2618) is an orally bioavailable inhibitor of (KIT) and (PDGFRA). Target: PDGFR, FLT, Apoptosis, VEGFR, c-Kit. Smiles: CCn1c2cc(NC)ncc2cc(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)c1=O. References: Schneeweiss M, et al. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. Haematologica. 2018 May,103(5):799-809.
Keywords: DCC-2618
Supplier: TargetMol
Supplier-Nr: T8482

Properties

Application: Targets proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1] (KIT, SCFR, CD117)
MW: 510.36 D
Formula: C24H21BrFN5O2

Database Information

CAS : 1442472-39-0| Matching products
KEGG ID : K04363 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Ripretinib"
Write a review
or to review a product.
Viewed